Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose

NCT07312292 is registered in ClinicalTrials.gov with Niek Wijnen as lead sponsor.

NCT NCT07312292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose
Lead sponsor
Niek Wijnen
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2026
Completion date
November 1, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer (locally advanced or metastatic), liver cancer adult